Increase your drug substance bioconjugate manufacturing capability
Benefit from years of experience in drug substance manufacturing across a broad spectrum of both platform and novel conjugation technologies. We can help you commercialize your drug candidate. We have a successful track record in process design and the execution of validation/conformance batches to support PAI, launch, and commercial manufacturing requirements.
We provide access to:
- Different GMP scales to produce flexible batch scales between 50g and multi Kilogram Batch Scale up to 6 kg
- Qualified stainless steel and single-use equipment
- Aseptic biopharmaceutical manufacturing environment
- cGMP facilities with safety procedures in place to handle cytotoxic compounds with OEL down to 1 ng/m3
- GMP facilities successfully inspected to deliver Bioconjugates Products into more than 60 countries globally
Technologies and products
Our GS Xceed® Expression System has options to engineer and express conjugation-competent antibodies. Applications include antibody drug conjugates (ADCs), half-life extension and imaging. Unlike other contract development and manufacturing organizations (CDMOs), we are in the unique position to offer complete development and manufacturing services of both mammalian cell culture and advanced chemical synthesis for the production of Antibody Drug Conjugates (ADCs). From process development to manufacturing scale-up, we offer integrated services tailored to your drug and designed to reduce program complexity and timelines.
Our locations
Locations where this service is provided
Visp, Switzerland
Founded in 1897, Lonza today is a dedicated strategic manufacturing partner to the healthcare industry, working with customers in the pharma, biotech and nutrition markets. Visp remains our largest site in a global network of more than 30 sites and one of the most significant for research and development and manufacturing.
Our Visp site is a complex of industry-leading facilities specializing in the development and manufacture of products for pharmaceutical applications including mammalian and microbial biopharmaceuticals, small molecules, highly potent APIs, peptides and bioconjugates including antibody-drug conjugates (ADCs). It is also home to our pioneering Ibex® Solutions services offering. Ibex® Solutions enables customers to accelerate their path throughout the complete biopharmaceutical lifecycle - from preclinical to commercial stages, from drug substance to drug product, all in one location.